Biom’up

Biom’up announces the approval of HEMOBLAST(TM) Bellows and its laparoscopic applicator in Australia

Biom’up: Approval of 2019 H1 interim results postponed: Board of Directors pursues review of options available to the Company

Biom’up strengthens management team

Biom’up: New Publication Highlights Application of HEMOBLAST(TM) Bellows in Cardiovascular Surgery

Biom’up issues a new tranche of EUR 5 million from the credit line granted by Athyrium

Biom’up Provides Business Update for the First Half of 2019 and confirms its Revenue Guidance for the year

Industry Veteran Dr. Jan Ohrstrom takes on Executive Leadership of Biom’up

Biom’up to Present at the RBC Capital Markets Global Healthcare Conference on Tuesday May 21, 2019 in New York City

Biom’up provides 2019 guidance for HEMOBLAST(TM) Bellows global sales

Biom’up reports 2018 full-year results and provides a business update

Biom’up erhält IDE-Genehmigung der FDA für HEMOSNOW(TM)

Biom’up granted FDA IDE approval for HEMOSNOW(TM)

Biom’up announces first US sales in laparoscopy for HEMOBLAST(TM) Bellows and the signing of an exclusive distribution agreement for HEMOBLAST(TM) Bellows in Australia

Biom’up Notice of 2018 Year End results

Biom’up appoints George Makhoul as Chief Commercial Officer (USA)

Biom’up HEMOBLAST(TM) Bellows full pivotal trial results published in Journal of Cardiac Surgery

Biom’up granted FDA approval for its HEMOBLAST(TM) Bellows Laparoscopic Applicator

Achievement of two major development milestones

Biom’up raises EUR3 million from the EUR10 million credit line granted in March 2018 by Athyrium

Biom’up: Biom’up schließt erfolgreich Privatplatzierung in Höhe von 7,67 Mio. EUR ab

Biom’up successfully closes a EUR7.67 million private placement financing

Biom’up launches a private placement financing of a minimum of EUR 7 million

Biom’up sees a strong commercial uptake in HEMOBLAST(TM) Bellows in the US and Europe

Biom’up announces completion of the 2018 scale-up of its manufacturing facility to meet commercial demand for HEMOBLAST(TM) Bellows